Explore Australia’s new Lung Cancer Screening Program, offering GPs practical guidance on eligibility, shared decision‑making, and navigating incidental findings.
A/Prof Greg Katsoulotos presents four case studies to demonstrate how best to manage patients who have asthma symptoms despite being on seemingly appropriate treatment.
Explore practical strategies for identifying and managing obstructive sleep apnoea in general practice, from screening tools and home-based sleep studies to weight loss, new medications and the role of technology.
This episode unpacks the new Australian lung cancer screening program, offering practical guidance for healthcare professionals on eligibility, pack year calculation, referrals, and managing common clinical challenges.
A practical discussion on interpreting additional findings in low dose CT lung cancer screening and how GPs can act early using the structured, guideline linked reporting system.
Could nasal saline benefit more patients than you think? In this Product Explainer, Allergist and Medical Rhinologist Dr Jessica Tattersall highlights the supportive role of nasal saline – both with and without the presence of sinonasal pathology – and raises important considerations when recommending nasal saline to patients (5 mins).
With obesity demonstrating mortality rates comparable to cigarette smoking and obstructive sleep apnoea (OSA) potentially affecting up to one billion people worldwide, the intersection of these conditions demands innovative therapeutic approaches.
Recent advances in incretin-based therapies, particularly the GLP-1/GIP receptor agonist tirzepatide (Mounjaro), are revolutionising treatment for patients with concurrent obesity and OSA, offering clinically significant improvements that may challenge traditional CPAP-centric management strategies.
In today’s episode, A/Prof Ramesh Balasubramaniam OAM presents a practical discussion on recognising, assessing and managing bruxism and TMJ disorders in everyday practice.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.
Podcasts
Videos
Clinical Articles
